Stephen Liu

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Boehringer Ingelheim
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol-Myers Squibb
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Catalyst
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eisai
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Elevation Oncology
    Date added:
    08/14/2023
    Date updated:
    08/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech/Roche
    Date added:
    08/14/2023
    Date updated:
    08/14/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond